Wigard Kloosterman

Company: Frame Cancer Therapeutics
Job title: CSO
Seminars:
Whole Framome Cancer vaccination 8:45 am
• Discovery of the full potential of frameshift neoantigens as targets of cancer immunotherapy • Personalized cancer immunotherapy using Framome neoantigen vaccinesRead more
day: Day One